Table 1.
Baseline patient characteristics
| CANA | LIRA | CANA/LIRA | P | |
|---|---|---|---|---|
| n | 12 | 12 | 12 | |
| Age (years) | 53 ± 6 | 53 ± 6 | 51 ± 8 | NS |
| Sex, n male/female | 8/4 | 8/4 | 6/6 | — |
| Weight (kg) | 98.1 ± 11.4 | 96.6 ± 8.4 | 98.8 ± 9.1 | NS |
| BMI (kg/m2) | 33.6 ± 6.5 | 34.8 ± 4.6 | 34.9 ± 4.4 | NS |
| Body fat (%) | 37.8 ± 6.7 | 36.9 ± 7.2 | 37.3 ± 7.7 | NS |
| HbA1c, % (mmol/mol) | 8.2 ± 1.2 (72.7 ± 10.6) | 8.4 ± 1.6 (68.3 ± 13.8) | 8.1 ± 1.8 (65.0 ± 15.3) | NS |
| FPG (mg/dL) | 173 ± 14 | 185 ± 16 | 182 ± 21 | NS |
| Treatment, n# | ||||
| Metformin | 3 | 3 | 2 | — |
| Metformin + sulfonylurea | 27 | 27 | 28 | — |
Data are mean ± SD unless otherwise indicated.
#All other participants were treated with diet alone.